CS403091A3 - 4-aryl-1,4-dihydropyridine-3,5-dicarboxylates,process of their preparation and pharmaceutical comprising them - Google Patents

4-aryl-1,4-dihydropyridine-3,5-dicarboxylates,process of their preparation and pharmaceutical comprising them

Info

Publication number
CS403091A3
CS403091A3 CS914030A CS403091A CS403091A3 CS 403091 A3 CS403091 A3 CS 403091A3 CS 914030 A CS914030 A CS 914030A CS 403091 A CS403091 A CS 403091A CS 403091 A3 CS403091 A3 CS 403091A3
Authority
CS
Czechoslovakia
Prior art keywords
dicarboxylates
dihydropyridine
aryl
pharmaceutical
preparation
Prior art date
Application number
CS914030A
Other languages
Czech (cs)
English (en)
Inventor
Alan David Borthwick
Original Assignee
Glaxo Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IT22383/84A external-priority patent/IT1175620B/it
Priority claimed from IT21460/85A external-priority patent/IT1187678B/it
Application filed by Glaxo Spa filed Critical Glaxo Spa
Publication of CS403091A3 publication Critical patent/CS403091A3/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C03—GLASS; MINERAL OR SLAG WOOL
    • C03B—MANUFACTURE, SHAPING, OR SUPPLEMENTARY PROCESSES
    • C03B2205/00—Fibre drawing or extruding details
    • C03B2205/44—Monotoring or regulating the preform feed rate

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CS914030A 1984-08-22 1991-12-23 4-aryl-1,4-dihydropyridine-3,5-dicarboxylates,process of their preparation and pharmaceutical comprising them CS403091A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT22383/84A IT1175620B (it) 1984-08-22 1984-08-22 Derivati piridinici
IT21460/85A IT1187678B (it) 1985-07-05 1985-07-05 Procedimento di preparazione di derivati eterociclici

Publications (1)

Publication Number Publication Date
CS403091A3 true CS403091A3 (en) 1992-06-17

Family

ID=26327905

Family Applications (1)

Application Number Title Priority Date Filing Date
CS914030A CS403091A3 (en) 1984-08-22 1991-12-23 4-aryl-1,4-dihydropyridine-3,5-dicarboxylates,process of their preparation and pharmaceutical comprising them

Country Status (33)

Country Link
US (2) US4801599A (ja)
JP (2) JPS6193162A (ja)
KR (1) KR920004482B1 (ja)
AT (1) AT394042B (ja)
AU (1) AU578724B2 (ja)
BE (1) BE903103A (ja)
BG (1) BG60409B2 (ja)
CA (1) CA1268180A (ja)
CH (1) CH666684A5 (ja)
CS (1) CS403091A3 (ja)
CY (1) CY1494A (ja)
DE (1) DE3529997C2 (ja)
DK (1) DK165949C (ja)
ES (5) ES8703839A1 (ja)
FI (1) FI81568C (ja)
FR (1) FR2569402B1 (ja)
GB (1) GB2164336B (ja)
GR (1) GR852016B (ja)
HK (1) HK52990A (ja)
HU (1) HU196754B (ja)
IE (1) IE58486B1 (ja)
LU (2) LU88267I2 (ja)
MX (1) MX159974A (ja)
NL (2) NL193065C (ja)
NO (2) NO167142C (ja)
NZ (1) NZ212895A (ja)
PH (1) PH22014A (ja)
PT (1) PT81000B (ja)
SA (1) SA91120277B1 (ja)
SE (1) SE459920B (ja)
SG (1) SG40889G (ja)
SK (1) SK278327B6 (ja)
ZW (1) ZW13185A1 (ja)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ212895A (en) * 1984-08-22 1988-07-28 Glaxo Spa 1,4-dihydropyridine derivatives and pharmaceutical compositions
AT394043B (de) * 1985-08-21 1992-01-27 Glaxo Spa Verfahren zur herstellung von neuen dihydropyridinderivaten
EP0226271B1 (en) * 1985-08-21 1990-11-22 GLAXO S.p.A. 1,4-dihydropyridine compounds and their preparation and pharmaceutical formulation
IT1204461B (it) * 1986-02-20 1989-03-01 Glaxo Spa Derivati eterociclici
IT1204462B (it) * 1986-02-20 1989-03-01 Glaxo Spa Derivati eterociclici
IT1204460B (it) * 1986-02-20 1989-03-01 Glaxo Spa Derivati eterociclici
IT1233370B (it) * 1988-11-21 1992-03-27 Glaxo Spa Procedimento di preparazione di derivati diidropipiridinici utili nel trattamento di disturbi cardiovascolari
EP0395369B1 (en) 1989-04-27 1997-07-02 Canon Inc. Optical recording medium and process for production thereof
US5177202A (en) * 1990-10-09 1993-01-05 Merck & Co., Inc. 2-phenanthrenyl-carbapenems
US5196529A (en) * 1990-10-09 1993-03-23 Merck & Co., Inc. 2-phenanthrenyl carbapenem intermediates
US5132422A (en) * 1990-10-09 1992-07-21 Merck & Co., Inc. 2-naphthyl-carbapenem intermediates
US5132421A (en) * 1990-10-09 1992-07-21 Merck & Co., Inc. 2-naphthyl-carbapenem intermediates
US5356889A (en) * 1990-08-01 1994-10-18 Merck & Co., Inc. 2-(9-fluorenonyl)-carbapenem intermediates
US5144028A (en) * 1990-10-09 1992-09-01 Merck & Co., Inc. 2-(9-fluorenonyl)-carbapenem intermediates
US5208329A (en) * 1990-10-09 1993-05-04 Merck & Co., Inc. 2-biphenyl carbapenem intermediates
IT1244728B (it) * 1991-02-13 1994-08-08 Glaxo Spa Impiego medicamentoso di derivati diidropiridinici
TW483763B (en) * 1994-09-02 2002-04-21 Astra Ab Pharmaceutical composition comprising of ramipril and dihydropyridine compound
WO2000027397A1 (en) * 1998-11-06 2000-05-18 Glaxo Group Limited Antihypertensive medicaments containing lacidipine and telmisartan
ATE502635T1 (de) 2002-08-19 2011-04-15 Pfizer Kombinationstherapie gegen hyperproliferative erkrankungen
NZ543741A (en) * 2003-05-30 2009-10-30 Ranbaxy Lab Ltd Substituted pyrrole derivatives and their use as HMG-Co inhibitors
US20050037063A1 (en) * 2003-07-21 2005-02-17 Bolton Anthony E. Combined therapies
KR20070054644A (ko) * 2004-07-26 2007-05-29 액테리온 파마슈티칼 리미티드 미립자 제형으로 흡입된 일로프로스트에 의한 폐고혈압의치료
EP1868577A4 (en) 2005-04-15 2009-12-09 Reddys Lab Inc Dr Lacidipine PARTICLE
US20070043088A1 (en) * 2005-08-16 2007-02-22 Eswaraiah Sajja Process for preparing lacidipine
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7893050B2 (en) * 2005-10-26 2011-02-22 Asahi Kasei Pharma Corporation Fasudil in combination therapies for the treatment of pulmonary arterial hypertension
EP2351569B1 (en) 2005-10-26 2012-08-22 Asahi Kasei Pharma Corporation Fasudil in combination therapies for the treatment of pulmonary arterial hypertension
JP2009514851A (ja) * 2005-11-08 2009-04-09 ランバクシー ラボラトリーズ リミテッド （３ｒ，５ｒ）−７−［２−（４−フルオロフェニル）−５−イソプロピル−３−フェニル−４−［（４−ヒドロキシメチルフェニルアミノ）カルボニル］−ピロール−１−イル］−３，５−ジヒドロキシ−ヘプタン酸ヘミカルシウム塩の製法
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
US7919506B2 (en) 2006-03-10 2011-04-05 Pfizer Inc. Dibenzyl amine compounds and derivatives
AR059838A1 (es) * 2006-03-14 2008-04-30 Ranbaxy Lab Ltd Formulaciones para dosis estabilizantes de estatina
JP2009543773A (ja) * 2006-07-14 2009-12-10 ランバクシー ラボラトリーズ リミテッド ＨＭＧ−ＣｏＡレダクターゼ阻害剤の多形体及びその使用
US20080089947A1 (en) * 2006-08-18 2008-04-17 Knox Clayton D Calcium Influx Inhibitors in the Treatment of Ischemia
JP5498168B2 (ja) 2006-12-01 2014-05-21 ブリストル−マイヤーズ スクイブ カンパニー アテローム性動脈硬化および循環器疾患の治療のためのｃｅｔｐ阻害剤としてのｎ−（（３−ベンジル）−２，２−（ビス−フェニル）−プロパン−１−アミン誘導体
US8883844B2 (en) 2010-09-24 2014-11-11 Nitrogenix Inc. Nitric oxide releasing amino acid ester for treatment of pulmonary hypertension and other respiratory conditions
EP2705839B1 (en) 2012-09-10 2018-02-21 Rivopharm SA Pharmaceutical composition comprising lacidipine and process of preparation
JP2016516804A (ja) 2013-04-17 2016-06-09 ファイザー・インク 心血管疾患を治療するためのｎ−ピペリジン−３−イルベンズアミド誘導体
WO2016055901A1 (en) 2014-10-08 2016-04-14 Pfizer Inc. Substituted amide compounds
JP7128969B2 (ja) 2019-01-18 2022-08-31 アストラゼネカ・アクチエボラーグ Ｐｃｓｋ９阻害剤及びその使用方法

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3455945A (en) * 1967-06-07 1969-07-15 Smithkline Corp 4-(carboxy (and carbo-lower alkoxy)phenyl)-1,4-dihydropyridines
DE2228363A1 (de) * 1972-06-10 1974-01-03 Bayer Ag 1,4-dihydropyridine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
GB1409865A (en) * 1973-02-13 1975-10-15 Science Union & Cie Dihydropyridines derivatives their preparation and pharmaceu tical compositions containing them
US4307103A (en) * 1978-09-08 1981-12-22 Fujisawa Pharmaceutical Co., Ltd. Dihydropyridine derivative, processes for preparation thereof and pharmaceutical composition comprising the same
DE3018259A1 (de) * 1980-05-13 1981-11-19 Bayer Ag, 5090 Leverkusen 1,4-dihydropyridine mit unterschiedlichen substituenten in 2- und 6-position, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
NZ201395A (en) * 1981-07-30 1987-02-20 Bayer Ag Pharmaceutical compositions containing 1,4-dihydropyridines and certain of these dihydropyridines
DE3207982A1 (de) * 1982-03-05 1983-09-08 Bayer Ag, 5090 Leverkusen Neue 1,4-dihydropyridine, verfahren zu ihrer herstellung und ihrer verwendung in arzneimitteln
NZ212895A (en) * 1984-08-22 1988-07-28 Glaxo Spa 1,4-dihydropyridine derivatives and pharmaceutical compositions

Also Published As

Publication number Publication date
NO167142C (no) 1991-10-09
NO1999007I1 (no) 1999-04-23
JPS6193162A (ja) 1986-05-12
SE8503888L (sv) 1986-02-23
US5011848A (en) 1991-04-30
HUT40625A (en) 1987-01-28
HK52990A (en) 1990-07-20
SE8503888D0 (sv) 1985-08-20
GB2164336B (en) 1988-06-08
BG60409B2 (bg) 1995-02-28
FI81568C (fi) 1990-11-12
CA1268180A (en) 1990-04-24
NL193065B (nl) 1998-05-06
DK378085D0 (da) 1985-08-20
GR852016B (ja) 1985-12-19
NL193065C (nl) 1998-09-08
PT81000A (en) 1985-09-01
AU4657685A (en) 1986-02-27
NL980037I1 (nl) 1999-02-01
KR870002073A (ko) 1987-03-28
NZ212895A (en) 1988-07-28
FR2569402B1 (fr) 1989-09-22
LU86047A1 (fr) 1986-02-28
GB2164336A (en) 1986-03-19
SG40889G (en) 1989-12-22
NL980037I2 (nl) 1999-03-01
JPS6479152A (en) 1989-03-24
SE459920B (sv) 1989-08-21
BE903103A (fr) 1986-02-24
ES8707930A1 (es) 1987-09-01
ES8802497A1 (es) 1988-07-01
ES552050A0 (es) 1987-09-01
ES8707931A1 (es) 1987-09-01
DK165949C (da) 1993-07-05
AU578724B2 (en) 1988-11-03
MX159974A (es) 1989-10-17
ES546324A0 (es) 1987-03-01
ES8707932A1 (es) 1987-09-01
NL8502296A (nl) 1986-03-17
PT81000B (pt) 1988-03-03
NO167142B (no) 1991-07-01
DE3529997A1 (de) 1986-03-06
PH22014A (en) 1988-05-02
FI853206L (fi) 1986-02-23
NO853293L (no) 1986-02-24
ES552049A0 (es) 1988-07-01
FI853206A0 (fi) 1985-08-21
ZW13185A1 (en) 1986-03-19
CY1494A (en) 1990-02-16
CH666684A5 (de) 1988-08-15
ES8703839A1 (es) 1987-03-01
SK278327B6 (en) 1996-11-06
SA91120277B1 (ar) 2006-05-15
DK165949B (da) 1993-02-15
US4801599A (en) 1989-01-31
JPH0686430B2 (ja) 1994-11-02
DK378085A (da) 1986-02-23
HU196754B (en) 1989-01-30
AT394042B (de) 1992-01-27
ATA245485A (de) 1991-07-15
GB8520924D0 (en) 1985-09-25
JPH0550506B2 (ja) 1993-07-29
KR920004482B1 (ko) 1992-06-05
FI81568B (fi) 1990-07-31
LU88267I2 (ja) 1994-02-03
DE3529997C2 (de) 1996-01-18
ES552048A0 (es) 1987-09-01
ES552051A0 (es) 1987-09-01
FR2569402A1 (fr) 1986-02-28
IE58486B1 (en) 1993-09-22
IE852054L (en) 1986-02-22

Similar Documents

Publication Publication Date Title
CS403091A3 (en) 4-aryl-1,4-dihydropyridine-3,5-dicarboxylates,process of their preparation and pharmaceutical comprising them
DE3572488D1 (en) Dialkoxyridines, process for their preparation, their application and medicaments containing them
HUT44499A (en) Process for producing 2-thio-methyl-substituted-1,4-dihydropyridines and pharmaceutical compositions containing them
GB2163648B (en) Pharmaceutical preparation and a method of making the same
IL84863A (en) 3-aryloxy-3-substituted propanamines,process for their preparation and pharmaceutical compositions comprising them
IL76366A (en) 2,6-dialkyl-4-aryl-3,5-diacyl-1,4-dihydropyridine derivatives,processes for their manufacture and pharmaceutical preparations containing them
EP0236059A3 (en) Preparation of erythropoietin-producing cells and production process of erythropoietin using same
IL75943A (en) 1,4-dihydropyridine derivatives,their preparation and pharmaceutical compositions containing them
IL80394A0 (en) Antihypertensive thieno-isoxazoles and thieno-pyrazoles,process for their preparation and pharmaceutical compositions containing them
EP0172004A3 (en) Quinolinones, process for their preparation and pharmaceutical compositions containing them
CS505587A3 (en) 4-pyridone derivatives, process of their preparation and pharmaceuticalcompositions comprising them
ZA852459B (en) Derivatives of hydroxy-4-2h-1-benzothiopyran-2-one,their preparation and applications
ZA853874B (en) Dihydropyridine preparations and process for their preparation
AR244216A1 (es) Iminofeniltiazolidinas, procedimiento de preparacion y metodo de uso.
ZA853877B (en) Dihydropyridine combination preparations and process for their preparation
IL88237A0 (en) Fluoromethoxyphenyl dihydropyridines,their preparation and pharmaceutical compositions containing them
CS382191A3 (en) Benzoxazol- and benzothiazolamine derivatives, process of their preparation and pharmaceuticals based thereon
IL75814A0 (en) Dihydropyridines,their production and pharmaceutical compositions containing them
GB2167034B (en) Capsules and process for their preparation
ZA853875B (en) Nifedipine preparations and process for their preparation
AR242193A1 (es) Procedimiento para la preparacion de 4-/4,5-dihidro-2-imidazolil(o 2-oxazolil o 2-tiazolil)7-amino-5(o 3,5)-halogeno benzamida e intermediarios de sintesis utilizados segun dicho procedimiento.
ZA853878B (en) Nifedipine combination preparations and process for their preparation
ZA857650B (en) Pyridine derivatives,a process of their preparation and therapeutic compositions containing said derivatives
ZA857381B (en) New hydroxy-thia-alkenes,their process of preparation and uses
PH22247A (en) Diazepinoindole, pharmaceutical composition and method of use thereof

Legal Events

Date Code Title Description
PD00 Pending as of 2000-06-30 in czech republic